Abstract
Transdermal drug delivery is a frequently exercised approach to allow the active molecules into the body through the skin owing to their advantages over other delivery systems. This approach can avoid the hepatic metabolism, provide the steady-state plasma drug concentration, evade the frequency of dosages by controlled release tendency, and improve patient compliance. The skin is the largest organ of the body, protects the influx of toxins, and controls essential compounds’ efflux. The stratum corneum (SC) is the first layer of the skin, controlling the permeation process across the skin and made up of dried lipid cells (keratinocytes). Elka Touitou designed ethosome-based drug delivery devices for transdermal delivery in 1997 since traditional skin distribution dosage forms have significant limitations in terms of drug penetration and permeation. Ethosomes are ethanol-embedded flexible vesicular systems having superior properties compared to other liposomes and transfersomes for skin delivery. Ethosomes, by their structure, mode of application, and action mechanism, are different from classic liposomes, transfersomes, and other lipid dispersions. This chapter explores the crux of conventional skin drug delivery systems, adoption of ethosomes as skin drug delivery systems, recent advances in their development, and current market status in the pharmaceutical industry.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- GIT:
-
gastrointestinal tract
- PG:
-
propylene glycol
- SC:
-
stratum corneum
- TDDS:
-
transdermal drug delivery system
- Tm:
-
phase transition temperature
References
Aggarwal N, Goindi S (2013) Dermato pharmacokinetic and pharmacodynamic evaluation of ethosomes of griseofulvin designed for dermal delivery. J Nanopart Res 15:1983
Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M (2013) Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm 443(1–2):26–38
Ainbinder D, Touitou E (2011) A new approach for skin tumor treatment: from delivery system characterization to in vivo evaluation. Drug Deliv Transl Res 1:53–65
Andrews SN, Jeong E, Prausnitz MR (2013) Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res 30:1099–1109
Apriani EF, Rosana Y, Iskandarsyah I (2019) Formulation, characterization, and in vitro testing of azelaic acid ethosome-based cream against Propionibacterium acnes for the treatment of acne. J Adv Pharm Technol Res 10:75–80
Ashoniya S, Meenakshi C (2011) Ethosomes as vesicular carrier for enhanced transdermal delivery of ketoconazole formulation and evaluation. J Pharm Cosmetol 1(3):1–14
Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252
Barry BW (1983) Dermatological formulations: percutaneous absorption. Marcel Dekker, New York and Basel
Barry BW (1988) Action of skin penetration enhancers-the lipid protein partitioning theory. Int J Cosmet Sci 10(6):281–293
Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–114
Benson HAE, Watkinson AC (2012) Topical and transdermal drug delivery. Wiley, Hoboken
Carter P, Narasimhan B, Wang Q (2019) Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases. Int J Pharm 555:49–62
Cevc G, Blume G (1992) Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104(1):226–232
Dave V, Kumar D, Lewis S, Paliwal S (2010) Ethosome for enhanced transdermal drug delivery of aceclofenac. Int J Drug Deliv 2(1):81–92
Dina F, Youssef EMK, Soliman GM (2020) Liposomal and ethosomal gels for the topical delivery of Anthralin preparation, comparative evaluation and clinical assessment in psoriatic patients. Pharmaceutics 12:446
Elias PM, Menon GK (1991) Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1–26
El Maghraby GM, Williams AC (2009) Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv 6:149–163
Fu X, Shi Y, Wang H, Zhao X, Sun Q, Huang Y, Qi T, Lin G (2019) Ethosomal gel for improving transdermal delivery of Thymosin β-4. Int J Nanomedicine 14:9275–9284
Godin B, Touitou E (2004) Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 94:365–379
Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M (2005) A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation an in vivo study. J Antimicrob Chemother 55:989–994
Goindi S, Dhatt B, Kaur A (2014) Ethosomes based topical delivery system of antihistaminic drug for treatment of skin allergies. J Microencapsul 31(7):716–724
Gunjan J, Swarnlata S (2014) Topical delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles. J Pharm Drug Deliv Res 3(1):100–118
Ita KB (2014) Transdermal drug delivery: progress and challenges. J Drug Del Sci Technol 24(3):245–250
Karadzovska D, Brooks JD, Monteiro Riviere NA, Riviere JE (2013) Predicting skin permeability from complex vehicles. Adv Drug Deliv Rev 65(2):265–277
Kaur CD, Saraf S (2011) Topical vesicular formulations of Curcuma longa extract on recuperating the ultraviolet radiation-damaged skin. J Cosmet Dermatol 10(4):260–265
Krishnan V, Mitragotri S (2020) Nanoparticles for topical drug delivery: potential for skin cancer treatment. Adv Drug Deliv Rev 153:87–108
Li G, Fan Y, Fan C (2012) Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm 82(1):49–57
Liu X, Liu H, Liu J (2011) Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomedicine 6:241–247
Lodzki M, Godin B, Rakou L, Mechoulam R, Touitou E (2003) Cannabidiol transdermal delivery and anti-inflammatory effect in a murine model. J Control Release 93:377–387
Madhavi N, Sudhakar B, Reddy KVNS, Ratna JV (2018) Pharmacokinetic and pharmacodynamic studies of etodolac loaded vesicular gels on rats by transdermal delivery. Daru 26(1):43–56
Madhavi N, Sudhakar B, Reddy KVNS, Ratna JV (2019) Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery. Drug Dev Ind Pharm 45(4):611–628
Mbah CC, Builders PF, Attama AA (2014) Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Expert Opin Drug Deliv 11(1):45–59
Martins M, Azoia NG, Ribeiro A, Shimanovich U, Silva C, Cavaco Paulo A (2013) In vitro and computational studies of transdermal perfusion of nano formulations containing a large molecular weight protein. Colloid Surface B 108:271–278
Mezei M, Gulasekharam V (1982) Liposomes, a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 34:473–474
Naik A, Kalia YN, Guy RH (2000) Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technol 3:318–326
Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M (2005) Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 106:99–110
Rakesh R, Anoop KR (2012) Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium. J Pharm Bioallied Sci 4(4):333–340
Rao LS (1984) Preparation of liposomes on the industrial scale problems and perspectives. In: Gregoriadis G (ed) Liposome technology, vol 1. CRC Press, Florida
RRC New (1990) Liposomes: a practical approach. Oxford University Press, New York
Scheuplein RJ (1976) Permeability of the skin: a review of major concepts and some new developments. J Invest Dermatol 67(5):672–676
Scheuplein RJ, Blank IH (1971) Permeability of the skin. Physiol Rev 51(4):702–747
Scheuplein RJ (1967) Mechanism of percutaneous absorption II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 48:79–88
Sage BH, Hoke RA, McFarland AC, Kowalcyk K (1993) The importance of skin pH in iontophoresis of peptides, prediction percutaneous penetration. STS Publishing Cardiff, pp 410–418
Shen S, Liu SZ, Zhang YS (2015) Compound antimalarial ethosomal cataplasm preparation evaluation, and mechanism of penetration enhancement. Int J Nanomedicine 10:4239–4253
Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD (2012) A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 92:299–304
Sudhakar CK, Nitish U, Sanjay J, Charyulu RN (2012) Ethosomes as non-invasive loom for transdermal drug delivery. Nanomed Drug Deliv Apple Academic Press, pp 1–16
Tachibana K (1992) Transdermal delivery of insulin to alloxan diabetic rabbits by ultrasound exposure. Pharm Res 9:952–954
Touitou E, Alkabes M, Dayan N, Eliaz M (1997) Ethosomes novel vesicular carriers for enhanced skin delivery. Pharm Res 14(S305)
Touitou E (1998) Composition for applying active substances to or through the skin. U.S. Patent 5:638–716
Touitou E (1996) Compositions for applying active substances to or through the skin. United States patent US 5540934 a
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65(3):403–441
Touitou B, Godin M, Shumilov N, Bishouty D, Ainbinder R, Shouval AI, Leibovici V (2008) Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris. J Eur Acad Dermatol Venerol 22(5):629–631
Verma P, Pathak K (2012) Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 8(4):489–496
Wu X, Guy RH (2009) Applications of nanoparticles in topical drug delivery and in cosmetics. J Drug Deliv Sci Technol 19(6):371–384
Xiang Y, Lina D, Yu L, Guiying F, Jin Y (2015) Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother 73:6–11
Yu Z, Lv H, Han G, Ma K (2016) Ethosomes loaded with Cryptotanshinone for acne treatment through topical gel formulation. PLoS One 11(7):e0159967
Zhang JP, Wei YH, Zhou Y, Li YQ, Wu XA (2012) Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride a comparative study. Arch Pharm Res 35(1):109–117
Zhang L, Li X, Zhu S, Zhang T, Maimaiti A, Ding M, Shi (2020) Dermal targeting delivery of terbinafine hydrochloride using novel multi-ethosomes: a new approach to fungal infection treatment. Coatings 10(4):304
Zhao YZ, Lu CT, Zhang Y (2013) Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. Int J Pharm 454(1):302–309
Zhou Y, Wei Y, Liu H, Zhang G, Wu X (2010) Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH-gradient method. AAPS Pharm Sci Tech 11(3):1350–1358
Nida, Akhtar Kamla, Pathak (2012) Cavamax W7 Composite Ethosomal Gel of Clotrimazole for Improved Topical Delivery: Development and Comparison with Ethosomal Gel. AAPS PharmSciTech 13(1) 344-355 10.1208/s12249-012-9754-y
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Madhavi, N., Sudhakar, B., Reddy, K.V.N.S. (2021). Ethosome: A Potential Tool for Drug Delivery Through the Skin. In: Kim, JC., Alle, M., Husen, A. (eds) Smart Nanomaterials in Biomedical Applications. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-84262-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-84262-8_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84261-1
Online ISBN: 978-3-030-84262-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)